Thanks again @TheCuriousInvestor, insightful qualitative analysis. The piece on using their shares instead of using cash is interesting and does make me wonder on whether their shares are overvalued.
There's indication from latest MD&A that we’ll see the full impact of cost-cutting & revenue accretion from recent acquisitions in Q4 / Q1, I am curious to whether they will separate the performance for transparency.
Thanks again @TheCuriousInvestor, insightful qualitative analysis. The piece on using their shares instead of using cash is interesting and does make me wonder on whether their shares are overvalued.
There's indication from latest MD&A that we’ll see the full impact of cost-cutting & revenue accretion from recent acquisitions in Q4 / Q1, I am curious to whether they will separate the performance for transparency.